Protection against Reinfection with the Omicron BA.2.75 Subvariant
| Author | Chemaitelly, Hiam |
| Author | Tang, Patrick |
| Author | Coyle, Peter |
| Author | Yassine, Hadi M. |
| Author | Al-Khatib, Hebah A. |
| Author | Smatti, Maria K. |
| Author | Hasan, Mohammad R. |
| Author | Ayoub, Houssein H. |
| Author | Altarawneh, Heba N. |
| Author | Al-Kanaani, Zaina |
| Author | Al-Kuwari, Einas |
| Author | Jeremijenko, Andrew |
| Author | Kaleeckal, Anvar H. |
| Author | Latif, Ali N. |
| Author | Shaik, Riyazuddin M. |
| Author | Abdul-Rahim, Hanan F. |
| Author | Nasrallah, Gheyath K. |
| Author | Al-Kuwari, Mohamed G. |
| Author | Butt, Adeel A. |
| Author | Al-Romaihi, Hamad E. |
| Author | Al-Thani, Mohamed H. |
| Author | Al-Khal, Abdullatif |
| Author | Bertollini, Roberto |
| Author | Abu-Raddad, Laith J. |
| Available date | 2023-03-28T07:05:00Z |
| Publication Date | 2023-01-01 |
| Publication Name | New England Journal of Medicine |
| Identifier | http://dx.doi.org/10.1056/NEJMc2214114 |
| Citation | Chemaitelly H, Tang P, Coyle P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Ayoub HH, Altarawneh HN, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ; National Study Group for COVID-19 Epidemiology. Protection against Reinfection with the Omicron BA.2.75 Subvariant. N Engl J Med. 2023 Feb 16;388(7):665-667. doi: 10.1056/NEJMc2214114. |
| ISSN | 00284793 |
| Abstract | The BA.2.75 sublineage of the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may escape neutralizing antibodies. The BA.2.75 sublineage (primarily the BA.2.75.2 subvariant) became the predominant sublineage in Qatar by September 10, 2022 (Section S1 and Fig. S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org). We estimated the effectiveness of previous infection with SARS-CoV-2 in preventing reinfection with BA.2.75 using a test-negative, case–control study design (Section S2).1 |
| Language | en |
| Publisher | Massachusetts Medical Society |
| Subject | Coronavirus Infectious Disease Vaccines Viral Infections |
| Type | Other |
| Pagination | 665-667 |
| Issue Number | 7 |
| Volume Number | 388 |
| ESSN | 1533-4406 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Biomedical Research Center Research [740 items ]